Risultati per: AGA: linee guida sulla de-prescrizione degli inibitori della pompa protonica

The purpose of this American Gastroenterological Association (AGA) Institute Clinical Practice Update (CPU) is to review the available evidence and provide expert advice regarding the diagnosis and management of cyclic vomiting syndrome.

This nonrandomized controlled trial assesses the feasibility of using a circulating tumor DNA−guided adaptive de-escalation tyrosine kinase inhibitor strategy in patients with advanced non−small cell lung cancer to achieve complete remission after local consolidative therapy.

It is an honor to write this piece celebrating Dr Hashem El-Serag as recipient of the American Gastroenterological Association (AGA) William Beaumont Prize in Gastroenterology (Photo 1). Established in 1976, this prize honors a senior investigator who has made a major contribution that has significantly advanced the care of patients with digestive diseases through clinical or translational research. This year, Hashem joins a cadre of 21 highly accomplished scientists who have received this award since its inception.

We are honored to write this biographical tribute for Jerrold Turner, MD, PhD, AGAF, marking his receipt of the American Gastroenterological Association (AGA) Distinguished Achievement Award in Basic Science.

Barrett’s esophagus (BE) is the precursor to esophageal adenocarcinoma (EAC). Endoscopic eradication therapy (EET) can be effective in eradicating BE and related neoplasia and has greater risk of harms and resource use than surveillance endoscopy. This clinical practice guideline aims to inform clinicians and patients by providing evidence-based practice recommendations for the use of EET in BE and related neoplasia.

Annals of Internal Medicine, Ahead of Print.